Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA OKs improved anaesthesia monitor:

This article was originally published in Clinica

Executive Summary

The US FDA has cleared for sale an easier-to-use version of Physiometrix' system for monitoring a patient's level of consciousness under anaesthesia. The new PSA 4000 monitor can now be used with the company's "frontal array" sensor - a disposable device that fits on the forehead of the patient being monitored. The clearance is expected to eliminate a considerable impediment to greater market acceptance of the PSA system, said John Williams, the North Billerica, Massachusetts firm's president and CEO. The company said it anticipated launching the product through its exclusive distribution partner, Baxter Healthcare, this month.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts